Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-21
2006-11-21
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S280000
Reexamination Certificate
active
07138402
ABSTRACT:
The present invention provides compounds represented by Formula I. R0is selected from hydrogen, halogen, lower alkyl, —SR8, —OR8, —CN, and —NHR8, R1is halogen, or lower alkyl; R2is —NHR8; R3is selected from the group consisting of hydrogen, halogen, —SR8, —OR8, —CN, —C(O)R9, —C(O)OH, —NO2, —NR8R10, lower alkyl, lower alkenyl, lower alkynyl, lower perhaloalkyl, aryl, heteroaryl, alicyclic and heterocyclic, all optionally substituted, and R5is aryl, heteroaryl, alicyclic, or heterocyclic:
REFERENCES:
patent: 4495190 (1985-01-01), Hagberg et al.
patent: 4547573 (1985-10-01), Jung et al.
patent: 4617304 (1986-10-01), Ashton et al.
patent: 4699877 (1987-10-01), Cline et al.
patent: 4748177 (1988-05-01), Sircar et al.
patent: 4772606 (1988-09-01), Sircar et al.
patent: 4774325 (1988-09-01), Casadio et al.
patent: 4806642 (1989-02-01), Sircar et al.
patent: 4918162 (1990-04-01), Slamon et al.
patent: 4921859 (1990-05-01), Sircar et al.
patent: 4923885 (1990-05-01), Hupe et al.
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5002950 (1991-03-01), Malone et al.
patent: 5098906 (1992-03-01), Sircar et al.
patent: 5110818 (1992-05-01), Allgeier
patent: 5204353 (1993-04-01), Meier
patent: 5217866 (1993-06-01), Summerton et al.
patent: 5332744 (1994-07-01), Chakravarty et al.
patent: 5602156 (1997-02-01), Kohn et al.
patent: 5656629 (1997-08-01), Bacon et al.
patent: 5789394 (1998-08-01), Nguyen-Ba et al.
patent: 5846749 (1998-12-01), Slamon et al.
patent: 5861503 (1999-01-01), Barrio et al.
patent: 5917042 (1999-06-01), Daluge et al.
patent: 5955610 (1999-09-01), Nguyen-Ba et al.
patent: 5994361 (1999-11-01), Penney et al.
patent: 6005107 (1999-12-01), Nguyen-Ba et al.
patent: 6143743 (2000-11-01), Wilde et al.
patent: 6174875 (2001-01-01), DeFranco et al.
patent: 6210974 (2001-04-01), Gold
patent: 6262254 (2001-07-01), Barrio et al.
patent: 6333331 (2001-12-01), Moschel et al.
patent: 6369092 (2002-04-01), Pamukcu et al.
patent: 6444656 (2002-09-01), Nguyen-Ba et al.
patent: 6723727 (2004-04-01), Peyman et al.
patent: 2002/0156277 (2002-10-01), Fick et al.
patent: 2002/0161014 (2002-10-01), Sadhu et al.
patent: 2003/0022864 (2003-01-01), Osjaq et al.
patent: 2003/0078413 (2003-04-01), Dempcy et al.
patent: 2004/0097526 (2004-05-01), Gillespie et al.
patent: 2004/0102458 (2004-05-01), Chiosis et al.
patent: 2005/0043239 (2005-02-01), Douangnanya et al.
patent: 2005/0049263 (2005-03-01), Kasibhatla et al.
patent: 2005/0113339 (2005-05-01), Kasibhatla et al.
patent: 2005/0113340 (2005-05-01), Kasibhatla et al.
patent: 2005/0119282 (2005-06-01), Kasibhatla et al.
patent: 2005/0256183 (2005-11-01), Kasibhatla et al.
patent: 55239 (1982-06-01), None
patent: 156559 (1985-10-01), None
patent: 159264 (1985-10-01), None
patent: 178178 (1986-04-01), None
patent: 206415 (1986-12-01), None
patent: 0184322 (1989-12-01), None
patent: 363320 (1990-04-01), None
patent: 151528 (1990-07-01), None
patent: 465297 (1992-01-01), None
patent: 502690 (1992-09-01), None
patent: 565377 (1993-10-01), None
patent: 675123 (1995-10-01), None
patent: 06080670 (1994-03-01), None
patent: 08041035 (1996-02-01), None
patent: 08208687 (1996-08-01), None
patent: 09020776 (1997-01-01), None
patent: 09169758 2 (1997-06-01), None
patent: 10025294 (1998-01-01), None
patent: 2000-072773 (2000-03-01), None
patent: 2003-113181 (2003-04-01), None
patent: WO-1986-05518 (1986-09-01), None
patent: WO-1989-10923 (1989-11-01), None
patent: WO-1992-05180 (1992-04-01), None
patent: WO-1995-07695 (1995-03-01), None
patent: WO-1995-08327 (1995-03-01), None
patent: WO-1998-01448 (1998-01-01), None
patent: WO-1998-39344 (1998-09-01), None
patent: WO-1998-51702 (1998-11-01), None
patent: WO-1999-01454 (1999-01-01), None
patent: WO-1999-02162 (1999-01-01), None
patent: WO-1999-12927 (1999-03-01), None
patent: WO-1999-24432 (1999-05-01), None
patent: WO-1999-32122 (1999-07-01), None
patent: WO-1999-51223 (1999-10-01), None
patent: WO-2000-06523 (2000-02-01), None
patent: WO-00-43394 (2000-07-01), None
patent: WO-2000-044750 (2000-08-01), None
patent: WO-2000-053394 (2000-09-01), None
patent: WO-2000-068230 (2000-11-01), None
patent: WO-2001-38584 (2001-05-01), None
patent: WO-2001-049688 (2001-07-01), None
patent: WO-2001-72779 (2001-10-01), None
patent: WO-2002-085905 (2001-10-01), None
patent: WO-2001-081346 (2001-11-01), None
patent: WO-2002-02123 (2002-01-01), None
patent: WO-2002-09696 (2002-02-01), None
patent: WO-2002-036075 (2002-05-01), None
patent: WO-2002-036171 (2002-05-01), None
patent: WO-2002-055082 (2002-07-01), None
patent: WO-2002-055083 (2002-07-01), None
patent: WO-2002-055521 (2002-07-01), None
patent: WO-2002-057288 (2002-07-01), None
patent: WO-2002-069900 (2002-09-01), None
patent: WO-2002-088079 (2002-11-01), None
patent: WO-2002-088080 (2002-11-01), None
patent: WO-2002-094196 (2002-11-01), None
patent: WO-2002-102314 (2002-12-01), None
patent: WO-2003-000200 (2003-01-01), None
patent: WO-2003-002565 (2003-01-01), None
patent: WO-2003-026571 (2003-04-01), None
patent: WO-2003-35938 (2003-05-01), None
patent: WO-2003-037860 (2003-05-01), None
patent: WO-2003-041643 (2003-05-01), None
patent: WO-2003-050295 (2003-06-01), None
patent: WO-2003-066005 (2003-08-01), None
patent: WO-2003-106458 (2003-12-01), None
patent: WO-2004-014913 (2004-02-01), None
patent: WO-2004-024082 (2004-03-01), None
patent: WO-2004-029064 (2004-04-01), None
patent: WO-2005-012324 (2005-02-01), None
patent: WO-2005-016348 (2005-02-01), None
patent: WO-2005-016349 (2005-02-01), None
patent: WO-2005-028434 (2005-03-01), None
U.S. Appl. No. 60/128,593, filed Apr. 9, 1999, Neal Rosen.
U.S. Appl. No. 60/293,246, filed May 23, 2001, Neal Rosen.
U.S. Appl. No. 60/331,893, filed Nov. 21, 2001, Lin Zhang.
U.S. Appl. No. 60/335,391, filed Oct. 30, 2001, Srinivas Kasibhatla.
U.S. Appl. No. 60/337,919, filed Nov. 9, 2001, Srinivas Kasibhatla.
U.S. Appl. No. 60/340,762, filed Dec. 12, 2001, Adeela Kamal.
U.S. Appl. No. 60/359,484, filed Feb. 25, 2002, Kevin Short.
U.S. Appl. No. 60/371,668, Ulm et al.
Abblard, J. et al., “Preparation et determination de structure de nouvelles pyridines halogenees Mecanisme de l'halagenation,” Bull. Soc. Chim. Fr. 1972, 2466.
Abramovitch Pyridine and its derivatives, Supp. Part 2, Wiley & Sons, 1974, pp. 1-2.
Alhede, J., “A Simple and Efficient Synthesis of 9-Substituted Guanines. Cyclodesulfurization of 1-Substituted-5;[(Thiocarbamoyl)amino]imidazole-4-carboxamides under Aqueous Basic Conditions,” Org. Chem. 1991, 2139.
Andricopulo, A.D. and Yunes, R.A., “Structure-activity relationships for a collection of structurally diverse inhibitors of purine nucleoside phosphorylase,” Chem. & Pharm. Bull. 49(1), 10-17 (2001).
Ashton, W.T. et al., “Synthesis and Antiherpetic Activity of (±)-9-[[(Z)-2-(Hydroxymethyl)cyclopropyl]methyl]guanine and Related Compounds,” J. Med. Chem. 1988, 31, 2304-2315.
Ashwell, M. et al., “An improved route to guanines substituted at N-9,” J. of the Chem. Soc., Chem. Comm. (14), 955-6 (1990).
Bakkestuen, A. K., et al., “9-Benzylpurines with inhibitory activity against Mycobacterium tuberculosis,” Biorg. & Med. Chem. Ltrs., 10(11), 1207-1210 (2000).
Baker, et al., “Irreversible Enzyme Inhibitors. XCV. 8-(m-Bromoacetamidobenzylthio) hypoxanthine, and Active-Site-Directed Irreversible Inhibitor of Xanthine Oxidase,” J. Medicinal Chem. 10(4), 682-685 (1967).
Balo, M.C. et al, “Synthesis of novel carbocyclic nucleosides with a cyclopentenyl ring: homocarbovir and analogs,” Tetrahedron 54(12), 2833-2842 (1998).
Balo, M.C. et al, “Synthesis and antiviral activies of some novel carbocyclic nucleosides,” Nucleosides & Nucleotides 15(7&8), 1335-1346 (1996).
Bedard, J. et al., “Comparative study of the anti-human cytomegalovirus activities and toxicities of a tetrahydrofuran phosphonate analog of guanosine and cidofovir,” Antimocrobial Agents & Chemo. 43(3), 55
Biamonte Marco A.
Boehm Marcus F.
Hong Kevin D.
Kasibhatla Srinivas R.
Le Brazidec Jean-Yves
Berch Mark L.
Conforma Therapeutics Corporation
Wilson Sonsini Goodrich & Rosati
LandOfFree
Pyrrolopyrimidines and related analogs as HSP90-inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolopyrimidines and related analogs as HSP90-inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolopyrimidines and related analogs as HSP90-inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3680394